Serina Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Serina Therapeutics, Inc. (SER) reported Increase (Decrease) in Contract with Customer, Liability of $57.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-03-31
- Serina Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2019-03-31 was $44.00K, a 70.67% decline year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-03-31 was $150.00K.
- Serina Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $57.00K.
- Serina Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was -$34.00K, a 124.82% decline from fiscal 2018.
- Serina Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was $137.00K.
- Serina Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2017 was -$84.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|
| 2020-12-31 | $57.00K 10-K · filed 2021-03-31 | |
| 2019-12-31 | -$34.00K 10-K · filed 2021-03-31 | |
| 2019-03-31 | $44.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $137.00K 10-K/A · filed 2020-03-31 | |
| 2018-03-31 | $150.00K 10-Q · filed 2019-05-15 | |
| 2017-12-31 | -$84.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |